highperformr logo

InVivo Therapeutics's Overview

Total employees4
HeadquartersCambridge
Founded2005

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is a clinical-stage biotechnology company dedicated to developing and commercializing groundbreaking treatments for individuals suffering from spinal cord injuries (SCI). Their pioneering approach centers around the Neuro-Spinal Scaffold™, an investigational bioresorbable polymer scaffold designed to be implanted at the site of injury. The company's mission is to redefine the prognosis for SCI patients, aiming to improve their neurological recovery and overall quality of life. They are focused on advancing their clinical programs and navigating the regulatory pathways to bring their therapies to market.

Where is InVivo Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for InVivo Therapeutics' research and development activities, clinical trial management, corporate strategy, finance, and administrative operations.

Notable Features:

Situated in Kendall Square, the facility benefits from proximity to world-class research institutions, a dense network of biotech companies, and a highly skilled talent pool. The building likely offers modern lab and office spaces tailored for life sciences companies.

Work Culture:

The work culture at InVivo Therapeutics is likely characterized by a strong scientific focus, a mission-driven approach to patient care, collaboration, and innovation, typical of a clinical-stage biotech company working on challenging medical conditions.

HQ Significance:

The Cambridge location is highly significant, providing InVivo Therapeutics with strategic advantages in terms of access to cutting-edge research, potential partnerships, clinical expertise, and investment opportunities essential for its growth and development of SCI therapies.

Values Reflected in HQ: The choice of location in a premier innovation hub reflects InVivo Therapeutics' commitment to scientific excellence, cutting-edge research, and collaboration in its pursuit of treatments for spinal cord injury.

Location:

As a clinical-stage company, InVivo Therapeutics's global presence is primarily defined by the locations of its clinical trial sites. While headquartered in the US, their studies may involve research hospitals and medical centers in North America and potentially other regions as their programs advance. Manufacturing of their investigational products and core R&D are likely managed from or through their US base, potentially with global contract research organizations (CROs) and contract manufacturing organizations (CMOs).

Street Address:

One Kendall Square, Building 1400W, Suite 14-103

City:

Cambridge

State/Province:

MA

Country:

USA

InVivo Therapeutics's Global Presence

N/A - Operations primarily centralized

Address: N/A

Focus is on executing clinical trials which may occur at various medical centers, rather than establishing distinct regional offices for broader commercial or R&D purposes at this stage.

Buying Intent Signals for InVivo Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of InVivo Therapeutics

As of April 2025, InVivo Therapeutics' leadership includes:

Richard Toselli, M.D. - President and Chief Executive Officer
Heather Hamel - Chief Financial Officer and Treasurer

Investors of InVivo Therapeutics

InVivo Therapeutics has been backed by several prominent investors over the years, including:

Publicly traded on NASDAQ (Symbol: NVIV)
Various institutional investors specializing in healthcare and biotechnology
Retail shareholders

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the past 12-18 months, a key executive appointment was Heather Hamel as CFO. Other significant changes are typically announced via press releases or SEC filings.

New Appointments:

Heather Hamel, Heather Hamel was appointed as Chief Financial Officer and Treasurer to lead the company's financial strategy and operations.

Technology (Tech Stack) used by InVivo Therapeutics

Discover the tools InVivo Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

InVivo Therapeutics Email Formats and Examples

InVivo Therapeutics likely uses a common professional email format, typically combining elements of an employee's name with the company domain.

[firstinitial][last]@invivotherapeutics.com

Format

rtoselli@invivotherapeutics.com

Example

80%

Success rate

News and media

GlobeNewswireJanuary 25, 2024

InVivo Therapeutics Announces Pricing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the pricing of a registered direct offering of 3,125,000 shares of its common stock at a purchase price of $0.80 per share. The gross proceeds from the offering are expected to be approximately $2.5 million, before deducting placement agent fees and other offering expenses....more

GlobeNewswireNovember 9, 2023

InVivo Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

InVivo Therapeutics reported its financial results for the third quarter ended September 30, 2023, and provided an update on its business operations, including progress on its INSPIRE 2.0 clinical study for acute spinal cord injury....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including InVivo Therapeutics, are just a search away.